The Management of Risk and Investment in Cell Therapy Process Development: A Case Study for Neurodegenerative Disease (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2217/rme-2018-0081
PubMed Identifier: 31210581
Publication URI: http://europepmc.org/abstract/MED/31210581
Type: Journal Article/Review
Parent Publication: Regenerative Medicine
Issue: 5
ISSN: 1746-0751